Comparison of Knowledge Regarding Human Papillomavirus (HPV) and Cervical Cancer in Students with or without Sexual Intercourse

Authors: F. Bakiri, T. Rexha, A. Mitre

Abstract:

The aim of our study was to compare knowledge of regarding HPV and cervical cancer in female student of 18 to 26 years old, with or without sexual intercourse. We conducted a questionnaire survey of the students (N=568), in Faculty of Natural Sciences, Tirana, Albania. Sexually experienced students were more likely to have heard of risk factors such as multiple sex partners, sexual intercourse before age 18, having contracted any sexually transmitted diseases, having genital warts, smoking cigarettes, use of oral contraceptive, poor diet or nutrition and using tampons. No significant sexually experience differences were observed in knowledge of the way of transmission of the virus associated with cervical cancer knowledge, the virus associated with cervical cancer knowledge, the prevention of cervical cancer knowledge. On the other hand strong significant sexually experience differences were observed in knowledge of the diagnostic way of cervical cancer and what HPV can cause knowledge.

Keywords: Risk factors, HPV, Cervical cancer, Albanian students.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1088052

References:

[1] F. Bakiri , T. Rexha , A. Mitre, The Seroprevalence of 35 Types of Human Papillomavirus in Albanian Women. Journal International Environmental Application Science, Turkey. Volume VII (Issue IV), 2012, pp. 734-737.
[2] J. Cuzick, P. Sasieni , P. Davies , J. Adams , C. Normand , A. Frater , M. van Ballegooijen , E. van den Akker , A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technology Assessment, 3, 1999, pp. 1–204.
[3] J. Douglas, Papillomavirus. In L. Goldman & D. Ausiello (Eds.), Cecil's Medicine, (23rd ed.). Philadelphia, PA: Saunders Elsevier, 2008.
[4] E. F. Dunne, E. R. Unger, M. Sternberg, G. McQuillan , D. C. Swan, S.S Patel . L.E. Markowitz, Prevalence of HPV infection among females in the United States. Journal of the American Medical Association, 297(8), 2007, pp. 813‐819.
[5] L. Eckert, G. Lentz, Infections of the lower genital tract: vulva, vagina, cervix, toxicshock syndrome, HIV infections. In V. Katz, G. Lentz, R. Lobo, & D. Gershenson, (Eds.). Comprehensive Gynecology (5th ed.). Philadelphia, PA: Mosby, 2007.
[6] R. Fielder, M. Carey, Predictors and consequences of sexual “hookups” among college students: A short-term prospective study. Archives of Sexual Behavior, Online First, 2009.
[7] K. Filipi, A.Tedeschini, F. Paolini, S. Celicu, S. Morici, M. Kota, E. Bucaj. F. de Marco, Genital human papillomavirus infection and genotype prevalence among albanian women: a cross-sectional study. j med virol.; 82(7), 2010, 1192-6.
[8] R. Herrero, A. Hildesheim, C. Bratti, M. Sherman, M. Hutchinson, J. Morales, et al,. A population‐based study of all grades of cervical neoplasia in rural Costa Rica. Journal of the National Cancer Institute, 92, 2000, pp. 6464–6473.
[9] K. Ingledue , R. Cottrell, A. Bernard, College women’s knowledge, perceptions and preventative behaviors regarding human papillomavirus infection and cervical cancer. American Journal of Health Studies,2004, 19, pp. 28-34.
[10] E. Lazcano‐Ponce, R. Herrero , N. Munoz , A. Cruz , K. V. Shah , P. Alonso, et al, Epidemiology of HPV Infection among women Mexican women with normal cervical cytology. International Journal of Cancer, 2001, 91, pp. 412‐420.
[11] L. E. Markowitz, E. F. Dunne, M. Saraiya, H. W. Lawson, H. Chesson, E. R. Unger, Quadrivalent Human Papillomavirus Vaccine. Recommendations of the Advisory Committee on Immunization Practices. CDC: Morbidity and Mortality Weekly Reports, 56, 2007, pp. 1–24.
[12] M. Molano, H. Posso, E. Weiderpass , A. J. van den Brule, M. Ronderos, S. Franceschi, et al, Prevalence and determinants of HPV infection among Colombian women with normal cytology. British Journal of Cancer, 87, 2002, 324‐33.
[13] N. Munoz, F. X. Bosch, S. de Sanjose , R. Herrero, X. Castellsague, K.V. Shah, et al,.Epidemiologic classification of Human Papillomavirus types associated with cervical cancer. New England Journal of Medicine, 2003, 348(6), pp. 518‐527.
[14] D. Parkin, The global health burden of infection‐ associated cancers in the year 2002. International Journal of Cancer, 2006, 118, pp. 3030‐3044.
[15] K.S. Reisinger, S.L. Block, E. Lazcano-Ponce , R. Samakoses, M.T. Esser, J. Erick, et al, Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11,16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: A randomized controlled trial. The Pediatric Infectious Disease Journal, 2007, 26(3), pp. 201-209.
[16] J. Shepherd, R. Weston, G. Peersman, I.Z. Napuli, Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer, 2000. In: The Cochrane Library Issue 1. Oxford: Update software.
[17] S. C. Thompson, K. Anderson, D. Freedman, J. Swan, Illusions of safety in a risky world: A study of college students' condom use. Journal of Applied Social Psychology, 2006, 26(3), pp. 189-210.
[18] L. P. Wong, I.C. Sam, Ethnically diverse female university students’ knowledge and attitudes toward human papillomavirus (HPV), HPV vaccination and cervical cancer. Eur J Obstet Gynecol Reprod Biol, 148, 2010.
[19] World Health Organization (WHO), Human Papillomavirus and cervical cancer, 2008. Available at http://www.who.int/immunization/topics/hpv /en/
[20] WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Albania, 2010. Available at www. who. int/ hpvcentre
[21] M. A. Gerend, S. C. Lee, J. E. Shepherd, Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis, 2007; 34: 468 –71.
[22] G. D. Zimet , Improving adolescent health: Focus on HPV vaccine acceptance. J Adolesc Health 2005; 37 (Suppl):S17–23.